Nektar TherapeuticsNKTRNASDAQ
Loading
Gross Profit Over TimeContracting
Percentile Rank21
3Y CAGR-7.9%
5Y CAGR-16.2%
Year-over-Year Change
Revenue minus cost of goods sold
3Y CAGR
-7.9%/yr
vs -50.5%/yr prior
5Y CAGR
-16.2%/yr
Recent acceleration
Acceleration
+42.6pp
Accelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $55.04M | -18.8% |
| 2024 | $67.74M | +26.7% |
| 2023 | $53.48M | -24.1% |
| 2022 | $70.42M | -8.6% |
| 2021 | $77.01M | -42.3% |
| 2020 | $133.44M | +43.1% |
| 2019 | $93.24M | -92.0% |
| 2018 | $1.17B | +321.7% |
| 2017 | $277.16M | +105.0% |
| 2016 | $135.22M | - |